13C Pyruvate DNP MR Spectroscopy for Lymphoma Treatment Response Assessment

NCT05600361 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Patient Outcome Assessment

Interventions

DRUG: hyperpolarized 13C-labeled pyruvate from dynamic nuclear polarization (DNP) magnetic resonance spectroscopy

Sponsor

Chang Gung Memorial Hospital